glp-1 light headed Glucagon-like peptide-1 medicines in neurological and psychiatric disorders GLP-1: A Breakthrough in Diabetes
Description
Ed Joins us to share helpful tips to keep you safe this summer.
GLP-1 receptor agonists used for the treatment of diabetes, have shown some neuroprotective effects in cellular and animal models of Alzheimers disease (AD) and Parkinsons disease (PD)
Vitamin D
Dining out on GLP-1s is possible
Hear how GLP-1s actually perform in real-world populations and how they impact costs.
Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration
